3r4l: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3r4l.jpg|left|200px]] | |||
The | <!-- | ||
The line below this paragraph, containing "STRUCTURE_3r4l", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
--> | |||
{{STRUCTURE_3r4l| PDB=3r4l | SCENE= }} | |||
===Human very long half life Plasminogen Activator Inhibitor type-1=== | |||
<!-- | |||
The line below this paragraph, {{ABSTRACT_PUBMED_21947232}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 21947232 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_21947232}} | |||
==About this Structure== | |||
[[3r4l]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3R4L OCA]. | |||
==Reference== | |||
<ref group="xtra">PMID:021947232</ref><ref group="xtra">PMID:012533669</ref><ref group="xtra">PMID:019082507</ref><references group="xtra"/> | |||
[[Category: Homo sapiens]] | |||
[[Category: Han, Q.]] | |||
[[Category: Jankun, J.]] | |||
[[Category: Skrzypczak-Jankun, E.]] | |||
[[Category: Yang, J.]] | |||
[[Category: Zheng, H.]] | |||
[[Category: Blood clotting]] | |||
[[Category: Carbohydrate]] | |||
[[Category: Pai-1]] | |||
[[Category: Plasminogen activator inhibitor type 1]] | |||
[[Category: Serine protease inhibitor]] | |||
[[Category: Very long half life]] | |||
Revision as of 11:24, 2 November 2011
Human very long half life Plasminogen Activator Inhibitor type-1Human very long half life Plasminogen Activator Inhibitor type-1
Template:ABSTRACT PUBMED 21947232
About this StructureAbout this Structure
3r4l is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Jankun J, Yang J, Zheng H, Han FQ, Al-Senaidy A, Skrzypczak-Jankun E. Remarkable extension of PAI-1 half-life surprisingly brings no changes to its structure. Int J Mol Med. 2012 Jan;29(1):61-4. doi: 10.3892/ijmm.2011.798. Epub 2011, Sep 22. PMID:21947232 doi:10.3892/ijmm.2011.798
- ↑ Chorostowska-Wynimko J, Swiercz R, Skrzypczak-Jankun E, Wojtowicz A, Selman SH, Jankun J. A novel form of the plasminogen activator inhibitor created by cysteine mutations extends its half-life: relevance to cancer and angiogenesis. Mol Cancer Ther. 2003 Jan;2(1):19-28. PMID:12533669
- ↑ . PMID:019082507